Cargando…

Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study

There is an increasing interest for monitoring circulating myeloid-derived suppressor cells (MDSCs) in cancer patients, but there are also divergences in their phenotypic definition. To overcome this obstacle, the Cancer Immunoguiding Program under the umbrella of the Association of Cancer Immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandruzzato, Susanna, Brandau, Sven, Britten, Cedrik M., Bronte, Vincenzo, Damuzzo, Vera, Gouttefangeas, Cécile, Maurer, Dominik, Ottensmeier, Christian, van der Burg, Sjoerd H., Welters, Marij J. P., Walter, Steffen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726716/
https://www.ncbi.nlm.nih.gov/pubmed/26728481
http://dx.doi.org/10.1007/s00262-015-1782-5
_version_ 1782411873724923904
author Mandruzzato, Susanna
Brandau, Sven
Britten, Cedrik M.
Bronte, Vincenzo
Damuzzo, Vera
Gouttefangeas, Cécile
Maurer, Dominik
Ottensmeier, Christian
van der Burg, Sjoerd H.
Welters, Marij J. P.
Walter, Steffen
author_facet Mandruzzato, Susanna
Brandau, Sven
Britten, Cedrik M.
Bronte, Vincenzo
Damuzzo, Vera
Gouttefangeas, Cécile
Maurer, Dominik
Ottensmeier, Christian
van der Burg, Sjoerd H.
Welters, Marij J. P.
Walter, Steffen
author_sort Mandruzzato, Susanna
collection PubMed
description There is an increasing interest for monitoring circulating myeloid-derived suppressor cells (MDSCs) in cancer patients, but there are also divergences in their phenotypic definition. To overcome this obstacle, the Cancer Immunoguiding Program under the umbrella of the Association of Cancer Immunotherapy is coordinating a proficiency panel program that aims at harmonizing MDSC phenotyping. After a consultation period, a two-stage approach was designed to harmonize MDSC phenotype. In the first step, an international consortium of 23 laboratories immunophenotyped 10 putative MDSC subsets on pretested, peripheral blood mononuclear cells of healthy donors to assess the level of concordance and define robust marker combinations for the identification of circulating MDSCs. At this stage, no mandatory requirements to standardize reagents or protocols were introduced. Data analysis revealed a small intra-laboratory, but very high inter-laboratory variance for all MDSC subsets, especially for the granulocytic subsets. In particular, the use of a dead-cell marker altered significantly the reported percentage of granulocytic MDSCs, confirming that these cells are especially sensitive to cryopreservation and/or thawing. Importantly, the gating strategy was heterogeneous and associated with high inter-center variance. Overall, our results document the high variability in MDSC phenotyping in the multicenter setting if no harmonization/standardization measures are applied. Although the observed variability depended on a number of identified parameters, the main parameter associated with variation was the gating strategy. Based on these findings, we propose further efforts to harmonize marker combinations and gating parameters to identify strategies for a robust enumeration of MDSC subsets. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00262-015-1782-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4726716
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-47267162016-02-02 Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study Mandruzzato, Susanna Brandau, Sven Britten, Cedrik M. Bronte, Vincenzo Damuzzo, Vera Gouttefangeas, Cécile Maurer, Dominik Ottensmeier, Christian van der Burg, Sjoerd H. Welters, Marij J. P. Walter, Steffen Cancer Immunol Immunother Original Article There is an increasing interest for monitoring circulating myeloid-derived suppressor cells (MDSCs) in cancer patients, but there are also divergences in their phenotypic definition. To overcome this obstacle, the Cancer Immunoguiding Program under the umbrella of the Association of Cancer Immunotherapy is coordinating a proficiency panel program that aims at harmonizing MDSC phenotyping. After a consultation period, a two-stage approach was designed to harmonize MDSC phenotype. In the first step, an international consortium of 23 laboratories immunophenotyped 10 putative MDSC subsets on pretested, peripheral blood mononuclear cells of healthy donors to assess the level of concordance and define robust marker combinations for the identification of circulating MDSCs. At this stage, no mandatory requirements to standardize reagents or protocols were introduced. Data analysis revealed a small intra-laboratory, but very high inter-laboratory variance for all MDSC subsets, especially for the granulocytic subsets. In particular, the use of a dead-cell marker altered significantly the reported percentage of granulocytic MDSCs, confirming that these cells are especially sensitive to cryopreservation and/or thawing. Importantly, the gating strategy was heterogeneous and associated with high inter-center variance. Overall, our results document the high variability in MDSC phenotyping in the multicenter setting if no harmonization/standardization measures are applied. Although the observed variability depended on a number of identified parameters, the main parameter associated with variation was the gating strategy. Based on these findings, we propose further efforts to harmonize marker combinations and gating parameters to identify strategies for a robust enumeration of MDSC subsets. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00262-015-1782-5) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-01-04 2016 /pmc/articles/PMC4726716/ /pubmed/26728481 http://dx.doi.org/10.1007/s00262-015-1782-5 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Mandruzzato, Susanna
Brandau, Sven
Britten, Cedrik M.
Bronte, Vincenzo
Damuzzo, Vera
Gouttefangeas, Cécile
Maurer, Dominik
Ottensmeier, Christian
van der Burg, Sjoerd H.
Welters, Marij J. P.
Walter, Steffen
Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
title Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
title_full Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
title_fullStr Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
title_full_unstemmed Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
title_short Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
title_sort toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726716/
https://www.ncbi.nlm.nih.gov/pubmed/26728481
http://dx.doi.org/10.1007/s00262-015-1782-5
work_keys_str_mv AT mandruzzatosusanna towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy
AT brandausven towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy
AT brittencedrikm towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy
AT brontevincenzo towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy
AT damuzzovera towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy
AT gouttefangeascecile towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy
AT maurerdominik towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy
AT ottensmeierchristian towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy
AT vanderburgsjoerdh towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy
AT weltersmarijjp towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy
AT waltersteffen towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy